about
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pa...
Read More
1.93
-0.01
(-0.52%)
773.9K
XNAS Volume
XNAS 26 Jan, 2026 4:16 PM (EST)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
Alector Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..